Sathgen Therapeutics Named Company of the Year 2024 by Silicon India Magazine
“Honoured and Thrilled: Sathgen Therapeutics Named Company of the Year 2024 by Silicon India Magazine!
We are incredibly proud to announce that Sathgen Therapeutics has been recognized as the Company of the Year for 2024 by Silicon India Magazine. This prestigious award is a testament to our team’s unwavering dedication, groundbreaking innovations, and commitment to pushing the boundaries of therapeutic research.
This recognition is not just an accolade, but a reflection of:
- Our relentless pursuit of scientific excellence.
- Breakthrough developments in the field of cancer therapeutics – treating the patient, not just the disease.
- The incredible talent and passion of our world-class team.
A huge thank you to Silicon India Magazine for this incredible honour, and to our team, partners, and supporters who have been instrumental in our journey.
For investors, Pharma companies interested in partnering opportunities please contact us at [email protected].”
“Congratulations, and thanks to the entire Sathgen Therapeutics team for working hard to develop this molecule as soon as possible to help cancer patients.”
Sendurai Mani is an Indian-American oncologist and molecular biologist. Currently holding the Dean’s Chair for Translational Oncology at Brown University Warren Alpert Medical School, Dr. Mani also serves as the Associate Director for Translational Oncology at the Legorreta Cancer Center at Alpert Medical School.
Dr. Mani’s research focuses on finding the mechanisms driving cancer metastasis and therapy resistance, particularly in breast cancer. He is renowned for his discovery of cancer stem cells and their role in tumor progression and treatment resistance.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023